2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
Playback speed
10 seconds
ASCO® 2024 Insights: "RegoMel Trial - Regorafenib in Patients With Pretreated Advanced Melanoma"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Iris Dirven
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Iris Dirven
32 views
June 7, 2024
Login to view comments.
Click here to Login